Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
MBOTthis companyMicrobot Medical Inc.	$1.14	-6.9×	1.18×	0×	-6.76×	-93.0%	0.0%	0.0%	0.0%	-16.9%	-18.8%	-14.3%	0.01×	0.23×	0×	23.33×	0.0%	2	8.03	2	C+
CLNNClene Inc.	$4.41	-2.22×	-3.29×	289.36×	-3.38×	-148.3%	78.5%	-11541.5%	-13086.5%	148.8%	-188.6%	-32.1%	-1.23×	-0.75×	-8.61×	0.83×	0.0%	2	-23.05	2	C
CNTXContext Therapeutics Inc.	$0.19	-3.87×	2.31×	0×	-2.05×	231.0%	0.0%	0.0%	0.0%	-59.7%	-65.5%	-18.9%	0×	1.82×	0×	8.52×	0.0%	2	-5.58	3	B
DCGODocGo Inc.	$0.27	-0.48×	0.6×	0.27×	-0.38×	-3393.8%	30.7%	-27.7%	-56.6%	-126.7%	-55.8%	31.1%	0.2×	0.13×	-87.92×	2.26×	0.0%	3	-2.61	3	B
NSPRInspireMD, Inc.	$0.65	-2.34×	2.37×	14.56×	-2.59×	-939.0%	29.5%	-547.0%	-543.3%	-88.4%	-82.2%	-28.1%	0.06×	0.12×	0×	5.74×	0.0%	2	-11.16	2	C+
ORMPOramed Pharmaceuticals Inc.	$3.97	1.86×	0.59×	59×	0.97×	-70.9%	0.7%	-754.4%	3202.5%	32.1%	-6.0%	-9.4%	0×	-0.6×	0×	6.98×	0.0%	3	3.38	5	S-
Peer median	—	-2.22×	0.6×	14.56×	-2.05×	-148.3%	29.5%	-547.0%	-56.6%	-59.7%	-65.5%	-18.9%	0×	0.12×	0×	5.74×	0.0%	2	-5.58	3	—